Test strip and method for rapid reverse typing detection of ABO blood type
The existing ABO blood type anti-forming detection method is solved by using artificially synthesized A and B blood type antigen hexacose conjugates and cured tracers on the detection line of the test strips, and the samples to be tested are added dropwise on the reaction diaphragm. The short shelf life and low sensitivity have achieved higher detection sensitivity and simplified operation procedures, which are suitable for rapid clinical testing.
Patent Information
- Application Number
- CN202411043454.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-31
- Publication Date
- 2024-11-12
AI Technical Summary
The existing ABO blood type anti-formulation detection methods have problems such as short shelf life of standard red blood cell reagents, requiring auxiliary equipment, complicated operation and low detection sensitivity, resulting in dyslexia of results and possible blood transfusion accidents.
The test strips for rapid anti-formulation of ABO blood type are used to detect ABO blood type, including substrates, rinsing pads, indicator pads, reaction diaphragms and absorption pads. The test line is coated with artificially synthesized blood type A and B antigen hexa sugar conjugates, which are directly in the reaction. The sample to be tested was added dropwise on the diaphragm, and the cured tracer and antibodies were used for immune responses to develop and interpret color.
It overcomes the problems of short shelf life and low detection sensitivity of standard red blood cell reagents, reduces the risk of manual operation errors, does not require equipment assistance, and has higher detection sensitivity, and is suitable for rapid clinical testing scenarios.
Smart Images

Figure CN118937704A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of immunological detection devices, and in particular to a test strip for rapid reverse typing detection of ABO blood types and a method thereof. Background Art
[0002] Human blood has many blood types. The most common blood type system is ABO blood type. ABO blood type is determined by both red blood cell surface antigens and antibodies in serum. Type A blood contains A antigens on red blood cells and anti-B antibodies in serum; Type B blood contains B antigens on red blood cells and anti-A antibodies in serum; Type O blood contains no A and B antigens on red blood cells, and anti-A and anti-B antibodies in serum; Type AB blood contains both A and B antigens on red blood cells, and no anti-A and anti-B antibodies in serum. A antigen and anti-A antibody, B antigen and anti-B antibody will undergo immune binding reactions, causing red blood cells to agglutinate. This principle can be used to detect the blood type of human blood. Among them, the method of using standard anti-A and anti-B antibodies to detect red blood cell antigens is called positive typing; using standard A and B antigens to detect antibodies in serum is called reverse typing. Only by testing positive and reverse typing at the same time can the ABO blood type be correctly determined.
[0003] At present, the most commonly used ABO blood typing reverse typing method in clinical laboratories is the hemagglutination test. The detection reagent is a standard red blood cell reagent (type A, type B and type O red blood cells), and the detection means are the slide method, test tube method or microcolumn agglutination method. However, it has the following defects: (1) The standard red blood cell reagent has a short shelf life, generally stored at 2-8°C for 3 months; (2) Auxiliary equipment is required for the detection. For the commonly used test tube method, the reaction requires the use of a centrifugal device, and the result needs to be shaken when interpreted, which is prone to microbial contamination and hemolysis, making the result difficult to interpret; (3) Each antibody is tested separately, the operation is cumbersome, and it is easy to cause errors in blood type identification and even serious transfusion accidents.
[0004] Chinese patent CN202280015658.2 discloses the application of a blood group antigen trisaccharide conjugate in blood group antibody detection, specifically blood group antigen trisaccharide A analog protein conjugate and blood group antigen trisaccharide B analog protein conjugate, the conjugated substance is hemocyanin or bovine serum albumin, which is applied to various types of blood group antibody detection. However, the structure of A antigen and B antigen in the human ABO blood type system is a hexasaccharide chain. The shortened sugar chain of the blood group antigen trisaccharide conjugate will cause the specific binding of blood group antigen and blood group antibody to be easily affected by steric hindrance, resulting in poor detection sensitivity. Therefore, a more sensitive ABO blood type reverse typing detection method is needed. Summary of the invention
[0005] In order to solve the above problems, the present invention provides a test strip and method for rapid reverse typing detection of ABO blood types.
[0006] The present invention adopts the following technical solutions:
[0007] A test strip for rapid reverse typing detection of ABO blood type comprises a substrate, above which a flushing pad, an indicator pad, a reaction membrane and an absorption pad are sequentially arranged along a chromatography direction, the flushing pad is used to carry a sample flushing liquid, the indicator pad is pre-coated with at least one solidified tracer, the reaction membrane is used to carry a sample to be tested and is pre-coated with at least two detection lines perpendicular to the chromatography direction, the detection lines comprise an A line and a B line, the A line is coated with an A blood type antigen hexasaccharide conjugate, the B line is coated with a B blood type antigen hexasaccharide conjugate, and the absorption pad is used to absorb liquid passing through the reaction membrane.
[0008] Furthermore, the sample to be tested is a serum sample to be tested or a plasma sample to be tested.
[0009] Furthermore, the solidified tracer is an anti-human IgM antibody.
[0010] Furthermore, the A blood group antigen hexasaccharide conjugate is a conjugate of artificially synthesized A blood group antigen hexasaccharide and bovine serum albumin, and the B blood group antigen hexasaccharide conjugate is a conjugate of artificially synthesized B blood group antigen hexasaccharide and bovine serum albumin.
[0011] Furthermore, the detection line also includes a Ctl line, and the Ctl line is coated with an antibody that can bind to the solidified tracer.
[0012] Further, the detection lines are arranged in the order of Ctl line, A line, and B line along the chromatographic direction on the reaction membrane sheet, or the detection lines are arranged in the order of Ctl line, B line, and A line along the chromatographic direction on the reaction membrane sheet.
[0013] Furthermore, it also includes a buffer pad arranged between the indicator pad and the reaction membrane.
[0014] Furthermore, the reaction membrane is any one of nitrocellulose membrane, cellulose acetate membrane, polyethylene membrane or nylon membrane.
[0015] Furthermore, the substrate is a polyester board.
[0016] A method for rapid reverse typing detection of ABO blood type, the method is based on the above-mentioned rapid reverse typing test strip for detecting ABO blood type, the method comprising the following steps:
[0017] S1, dropping 5-10ul of the sample to be tested on the reaction membrane, wherein the sample to be tested is a serum sample to be tested or a plasma sample to be tested;
[0018] S2, dripping 50-100 ul of sample flushing liquid on the flushing pad, so that the sample flushing liquid gradually flows toward the absorption pad along the chromatography direction;
[0019] S3. If the A line is colored, it means that the sample to be tested contains anti-A blood type antibodies. If the B line is colored, it means that the sample to be tested contains anti-B blood type antibodies. At the same time, the ctl line is used as a control line and must be colored, otherwise the test strip will be invalid.
[0020] After adopting the above technical solution, the present invention has the following advantages compared with the background technology:
[0021] 1. The test strip of the present invention adopts an artificially synthesized blood type antigen hexasaccharide conjugate coated on the test line to replace the standard red blood cells, which overcomes the short shelf life of the existing standard red blood cell reagents. During the test, only a small amount of sample is added once to determine whether the sample contains anti-A or anti-B. The required sample amount is small, and the risk of manual operation errors is reduced. No equipment assistance is required, it can be stored at room temperature, has a long shelf life, and is more suitable for clinical blood type rapid detection scenarios.
[0022] 2. The A blood type antigen hexasaccharide conjugate and the B blood type antigen hexasaccharide conjugate used in the present invention have a single structure without interference from other blood type systems, and the sugar chain structure of the hexasaccharide chain is closer to the natural blood type antigen, which not only ensures the specific binding of blood type antigen and antibody, but also makes up for the defect of poor detection sensitivity.
[0023] 3. The test strip of the present invention adopts a method of directly dropping the sample to be tested on the reaction membrane, firstly allowing the blood type antibody in the sample to be tested to bind with the solidified blood type antigen, and then the tracer anti-human IgM antibody reaches the detection area with the flushing liquid and binds with the blood type antibody, thereby solving the problem of other IgM antibodies (i.e. non-blood type IgM antibodies) in the sample to be tested binding with the anti-human IgM antibody, making the detection sensitivity higher. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 It is a schematic diagram of the structure of the test strip of the present invention;
[0025] Figure 2 is the chemical structural formula of the A blood group antigen hexasaccharide conjugate;
[0026] Figure 3 It is the chemical structural formula of the B blood group antigen hexasaccharide conjugate.
[0027] Description of reference numerals:
[0028] 10. Substrate;
[0029] 11. Flushing pad;
[0030] 12. Indicator pad;
[0031] 13. Buffer pad;
[0032] 14, reaction diaphragm; 141, Ctl line; 142, A line; 143, B line;
[0033] 15. Absorbent pad. DETAILED DESCRIPTION
[0034] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0035] Example
[0036] like Figure 1 As shown, a rapid reverse typing test strip for detecting ABO blood type comprises a substrate 10, on which a flushing pad 11, an indicator pad 12, a buffer pad 13, a reaction membrane 14 and an absorption pad 15 are arranged in sequence along the chromatography direction. The flushing pad 11 is used to carry the sample flushing liquid, the indicator pad 12 is pre-coated with a solidified tracer, i.e., anti-human IgM antibody, and the reaction membrane 14 is used to carry the sample to be tested (the sample to be tested is a serum sample to be tested or a plasma sample to be tested). ) and the reaction membrane 14 is pre-coated with at least two detection lines perpendicular to the chromatography direction, the detection lines include a Ctl line 141, an A line 142 and a B line 143, the Ctl line 141 is coated with an antibody that can bind to the solidified tracer, the A line 142 is coated with an A blood type antigen hexasaccharide conjugate, and the B line 143 is coated with a B blood type antigen hexasaccharide conjugate, and the absorption pad 15 is used to absorb the liquid after passing through the reaction membrane 14.
[0037] The A blood group antigen hexasaccharide conjugate is a conjugate of an artificially synthesized A blood group antigen hexasaccharide and bovine serum albumin, and the B blood group antigen hexasaccharide conjugate is a conjugate of an artificially synthesized B blood group antigen hexasaccharide and bovine serum albumin. Specifically, the chemical structural formulas of the A blood group antigen hexasaccharide conjugate and the B blood group antigen hexasaccharide conjugate are as follows: Figure 2 and Figure 3 shown.
[0038] The standard red blood cells or blood group antigen trisaccharide conjugates used in the currently disclosed reverse typing detection of ABO blood type all have certain defects. When using standard red blood cells to detect ABO blood type, the rupture of the standard red blood cells will lead to the exposure of internal antigen sugar groups and changes in spatial conformation, thereby affecting the nonspecific binding of blood group antigens and blood group antibodies. In addition, the presence of antigens from other blood group systems on the extracted standard red blood cell membrane will also affect the detection of ABO blood group antibodies. For blood group antigen trisaccharide conjugates, their sugar chains are shorter, which will lead to increased steric hindrance during the specific binding of blood group antigens and antibodies, affecting the detection sensitivity. The A blood group antigen hexasaccharide conjugate and the B blood group antigen hexasaccharide conjugate used in this embodiment are both hexasaccharide chains, with a single structure and no interference from other blood group systems, and the sugar chain structure is closer to natural blood group antigens, which not only ensures the specific binding of blood group antigens and antibodies, but also makes up for the defect of poor detection sensitivity.
[0039] The detection lines are arranged on the reaction membrane sheet 14 in the order of Ctl line 141, A line 142, and B line 143 along the chromatography direction.
[0040] In this embodiment, the reaction membrane 14 is a nitrocellulose membrane, and the substrate 10 is a polyester board.
[0041] Taking the above test strip as an example, it is used to detect human serum ABO blood type antibodies, the method is as follows:
[0042] S1, dropping 5ul of the serum sample to be tested on the reaction membrane 14;
[0043] S2, dripping 50ul of sample washing liquid on the washing pad 11, so that the sample washing liquid gradually flows toward the absorption pad 15 along the chromatography direction; the sample washing liquid contains a PBS isotonic solution of an anionic surfactant;
[0044] S3. Wait for 10 minutes to read the results. Refer to Table 1 below for the reading results.
[0045] Table 1 Results of human serum ABO blood type antibody detection
[0046] A Line Line B Ctl Line ABO blood type Remark Color No color Color Type B Contains only anti-A blood group antibodies No color Color Color Type A Contains only anti-B blood group antibodies Color Color Color Type O Contains anti-A blood group antibodies and anti-B blood group antibodies No color No color Color Type AB Does not contain anti-A blood group antibodies and anti-B blood group antibodies / / No color Invalid test /
[0047] The detection principle is: an immune complex (the complex is anti-human IgM-blood type antibody-blood type antigen labeled with a tracer) is formed on line A 142 or line B 143, and then color is developed. Specifically, if line A 142 is colored, it means that the sample to be tested contains anti-A blood type antibodies, and if line B 143 is colored, it means that the sample to be tested contains anti-B blood type antibodies. At the same time, line CTL 141 is used as a control line and must be colored, otherwise the test strip will be invalid.
[0048] When the test strip of the present embodiment is used for reverse typing detection of ABO blood type, an artificially synthesized blood type antigen hexasaccharide conjugate is used instead of standard red blood cells, thereby overcoming the short shelf life of existing standard red blood cell reagents. When the test strip of the present embodiment detects ABO blood type, only a small amount of sample is required once (adding 5ul of the sample to be tested) to determine whether the sample contains anti-A or anti-B. The required sample amount is small, and the risk of manual operation errors is reduced. No equipment assistance is required, and it can be stored at room temperature. It has a long shelf life and is more suitable for clinical blood type rapid detection scenarios.
[0049] In addition, the existing test strips all adopt the method of dripping the sample to be tested on the sample pad. When used for reverse typing detection of ABO blood type, there will be a problem of low sensitivity due to the non-blood type IgM antibodies replacing part of the blood type IgM antibodies and binding to the tracer (specific binding substance of human IgM). This embodiment adopts the method of directly dripping the sample to be tested on the reaction membrane 14, firstly making the blood type antibodies in the sample to be tested bind to the solidified blood type antigen, and then the tracer anti-human IgM antibodies reach the detection area with the flushing liquid and bind to the blood type antibodies, thereby solving the problem of other IgM antibodies (i.e. non-blood type IgM antibodies) in the sample to be tested binding to the anti-human IgM antibodies, making the detection sensitivity higher.
[0050] The above is only a preferred specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed by the present invention should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.
Claims
1. A test strip for rapid reverse typing of ABO blood type, Features: The invention comprises a substrate, wherein a flushing pad, an indicator pad, a reaction membrane and an absorption pad are sequentially arranged above the substrate along a chromatography direction, wherein the flushing pad is used to carry a sample flushing liquid, the indicator pad is pre-coated with at least one solidified tracer, the reaction membrane is used to carry a sample to be tested and is pre-coated with at least two detection lines perpendicular to the chromatography direction, the detection lines comprise an A line and a B line, the A line is coated with an A blood type antigen hexasaccharide conjugate, the B line is coated with a B blood type antigen hexasaccharide conjugate, and the absorption pad is used to absorb liquid passing through the reaction membrane.
2. A test strip for rapid reverse typing of ABO blood type as claimed in claim 1, Features: The sample to be tested is a serum sample to be tested or a plasma sample to be tested.
3. A test strip for rapid reverse typing of ABO blood type as claimed in claim 2, Features: The immobilized tracer is an anti-human IgM antibody.
4. A test strip for rapid reverse typing of ABO blood type as claimed in claim 3, Features: The A blood group antigen hexasaccharide conjugate is a conjugate of artificially synthesized A blood group antigen hexasaccharide and bovine serum albumin, and the B blood group antigen hexasaccharide conjugate is a conjugate of artificially synthesized B blood group antigen hexasaccharide and bovine serum albumin.
5. A test strip for rapid reverse typing of ABO blood type as claimed in claim 4, Features: The detection line also includes a Ctl line, and the Ctl line is coated with an antibody that can bind to the solidified tracer.
6. A test strip for rapid reverse typing of ABO blood type as claimed in claim 5, Features: The detection lines are arranged in the order of Ctl line, A line, and B line along the chromatographic direction on the reaction membrane sheet, or the detection lines are arranged in the order of Ctl line, B line, and A line along the chromatographic direction on the reaction membrane sheet.
7. A test strip for rapid reverse typing of ABO blood types as claimed in claim 6, Features: Also included is a buffer pad disposed between the indicator pad and the reaction membrane.
8. A test strip for rapid reverse typing of ABO blood types as claimed in claim 7, Features: The reaction membrane is any one of nitrocellulose membrane, cellulose acetate membrane, polyethylene membrane or nylon membrane.
9. A test strip for rapid reverse typing of ABO blood type as claimed in claim 8, Features: The substrate is a polyester board.
10. A method for rapid reverse typing of ABO blood type, Features: The method is based on a rapid reverse typing test strip for detecting ABO blood type as described in claims 1 to 9, and the method comprises the following steps: S1, dropping 5-10ul of the sample to be tested on the reaction membrane, wherein the sample to be tested is a serum sample to be tested or a plasma sample to be tested; S2, dripping 50-100 ul of sample flushing liquid on the flushing pad, so that the sample flushing liquid gradually flows toward the absorption pad along the chromatography direction; S3. If the A line is colored, it means that the sample to be tested contains anti-A blood type antibodies. If the B line is colored, it means that the sample to be tested contains anti-B blood type antibodies. At the same time, the ctl line is used as a control line and must be colored, otherwise the test strip will be invalid.
Citation Information
Patent Citations
Application of blood group antigen trisaccharide conjugate in blood group antibody detection
CN116868059A
